Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Change in Accured Expenses: 2020-2024

Historic Change in Accured Expenses for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to -$371,821.

  • iSpecimen's Change in Accured Expenses rose 124.02% to $71,311 in Q3 2025 from the same period last year, while for Sep 2025 it was -$305,495, marking a year-over-year decrease of 5367.96%. This contributed to the annual value of -$371,821 for FY2024, which is 4068.63% down from last year.
  • According to the latest figures from FY2024, iSpecimen's Change in Accured Expenses is -$371,821, which was down 4,068.63% from $9,369 recorded in FY2023.
  • In the past 5 years, iSpecimen's Change in Accured Expenses registered a high of $2.0 million during FY2020, and its lowest value of -$1.7 million during FY2021.
  • Its 3-year average for Change in Accured Expenses is $52,994, with a median of $9,369 in 2023.
  • Per our database at Business Quant, iSpecimen's Change in Accured Expenses surged by 130.51% in 2022 and then tumbled by 4,068.63% in 2024.
  • iSpecimen's Change in Accured Expenses (Yearly) stood at $2.0 million in 2020, then slumped by 187.57% to -$1.7 million in 2021, then soared by 130.51% to $521,435 in 2022, then crashed by 98.20% to $9,369 in 2023, then plummeted by 4,068.63% to -$371,821 in 2024.